Both in Pharmaceuticals
CNS Pharmaceuticals vs Ensysce Biosciences
Over the past year CNSP returned −44.0% and ENSC returned −78.6%; their daily moves had a correlation of 0.10.
CNSP −44.0% ENSC −78.6%Growth of $1, one year, split-adjusted
| Metric | CNSP | ENSC |
|---|---|---|
| Price | $4.51 | $0.4523 |
| Market cap | $6.6M | $8.8M |
| Today | −11.22% | +0.53% |
| 1 month | −8.1% | +8.5% |
| 6 months | +99.6% | +25.2% |
| Year to date | −14.1% | −50.8% |
| 1 year | — | −78.9% |
| Revenue growth (YoY) | — | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $20.0M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 68.5% | 122.1% |
| Short % of float | 0.1% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).